Seroprevalence of SARS-COV-2 Antibodies Associated with the Use of Personal Protective Equipment in Healthcare Workers
- PMID: 39749151
- PMCID: PMC11693126
- DOI: 10.5455/msm.2024.36.222-228
Seroprevalence of SARS-COV-2 Antibodies Associated with the Use of Personal Protective Equipment in Healthcare Workers
Abstract
Background: Hypothetically, PPE played an estimated influential role in preventing SARS-CoV-2 transmission among HCWs before immune-prophylaxis by vaccination in BH. Objective: This research aims to determine the relationship between PPE use and the serological response to SARS-COV-2 among HCWs.
Methods: The sample contained 127 COVID-19 outpatients with an average age of 43.5 ± 10.8, 66% women, and 80 (63%) health workers as the study group (37% non-medical workers as a control subjects). The created questionnaire collected sociodemographic data on comorbidity or not, application of PPE, and severity of the clinical picture of COVID-19 infection.
Results: All subjects were monitored for the dynamics of antibodies, separately for IgM- and Ig-G three times, repeated every 3 months (only three before immuno-prophylaxis by vaccinations). A serological investigation of subjects' blood was collected by trained medical staff in vacutainers with a clotting activator to obtain the subjects' serum centrifuged, separated, and tested on the AFIAS 6 COVID-19 apparatus. Healthcare workers who did not wear goggles had significantly higher IgM antibody levels than HCWs who use them [F=9.359 (1, 102), p=.003, partial η2=.084]. Also, HCWs who did not use a visor had significantly higher IgM nucleocapsid antibody titer than those who used it daily or occasionally [F=4.790 (1, 102), p=.031, partial η2=.045]. Increase SARAS-COV-2 IgM titer three, six, or nine months after past COVID-19 infection and before vaccination.
Conclusion: It presents a new acute or recent asymptomatic infection in our HCWs and unrecognized COVID-19. This implies considerable source and unrecognized risk of transmission of the SARS-COV-2 virus, and among HCWs, COVID-19 is an infectious disease with a high prevalence rate.
Keywords: COVID-19; IgM and IgG; SARS-COV-2; healthcare workers; seroprevalence.
© 2024 Amela Dubinovic-Rekic, Nurka Pranjic.
Conflict of interest statement
None to declare.
Figures
References
-
- Huang Y, Yang L, Dai M, Tian F, Chen K. Epidemic situation and forecasting of COVID-19 in and outside China. J Infect. Bull World Health Organ. 2020 (E-pub ahead of print)
-
- European Centre for Disease Prevention and Control. Download historical data (to 14 December 2020) on the daily number of new reported COVID-19 cases and deaths worldwide. ECDC. 2020. https://opendata.ecdc.europa.eu/covid19/case distribution/csv.
-
- Nicoll A, Rrias VLC. Van-Tam J, editor. National and international public health measures. Pandemic Influence. CABI Digital Library. 2012:152–163.
-
- Ponjavić M, Karabegović A, Ferhatbegović E, Tahirović E, Uzunović S, Travar M, et al. Spatial-temporal data visualization for monitoring of control measures in the prevention of the spread of COVID-19 in Bosnia and Herzegovina. Med Glas (Zenica) 2020;17(2):265–274. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous